Great West Life Assurance Co. Can lessened its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 3.1% during the first quarter, HoldingsChannel.com reports. The fund owned 281,006 shares of the medical technology company’s stock after selling 8,908 shares during the quarter. Great West Life Assurance Co. Can’s holdings in Hill-Rom were worth $29,679,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the company. Securian Asset Management Inc raised its stake in shares of Hill-Rom by 1.2% in the 4th quarter. Securian Asset Management Inc now owns 8,231 shares of the medical technology company’s stock valued at $729,000 after acquiring an additional 100 shares during the period. Mastrapasqua Asset Management Inc. raised its stake in shares of Hill-Rom by 0.7% in the 4th quarter. Mastrapasqua Asset Management Inc. now owns 14,830 shares of the medical technology company’s stock valued at $1,313,000 after acquiring an additional 105 shares during the period. Johanson Financial Advisors Inc. raised its stake in shares of Hill-Rom by 4.8% in the 4th quarter. Johanson Financial Advisors Inc. now owns 2,437 shares of the medical technology company’s stock valued at $217,000 after acquiring an additional 111 shares during the period. Avitas Wealth Management LLC raised its stake in shares of Hill-Rom by 0.5% in the 1st quarter. Avitas Wealth Management LLC now owns 22,829 shares of the medical technology company’s stock valued at $2,417,000 after acquiring an additional 119 shares during the period. Finally, US Bancorp DE raised its stake in shares of Hill-Rom by 3.2% in the 1st quarter. US Bancorp DE now owns 5,068 shares of the medical technology company’s stock valued at $536,000 after acquiring an additional 155 shares during the period. 81.32% of the stock is currently owned by institutional investors and hedge funds.
A number of equities analysts have recently commented on HRC shares. ValuEngine downgraded shares of Hill-Rom from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Needham & Company LLC reissued a “buy” rating and issued a $116.00 target price on shares of Hill-Rom in a research note on Monday, March 11th. Zacks Investment Research raised shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $118.00 target price on the stock in a research note on Tuesday, April 16th. Finally, Barclays raised their price target on shares of Hill-Rom from $103.00 to $108.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Hill-Rom has an average rating of “Buy” and a consensus price target of $109.88.
HRC opened at $97.31 on Friday. The firm has a market cap of $6.50 billion, a P/E ratio of 20.49, a PEG ratio of 1.66 and a beta of 0.91. Hill-Rom Holdings, Inc. has a twelve month low of $81.82 and a twelve month high of $108.68. The company has a quick ratio of 1.27, a current ratio of 1.69 and a debt-to-equity ratio of 1.10.
Hill-Rom (NYSE:HRC) last released its quarterly earnings results on Friday, April 26th. The medical technology company reported $1.14 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.03. The business had revenue of $714.20 million during the quarter, compared to analyst estimates of $705.59 million. Hill-Rom had a net margin of 7.93% and a return on equity of 21.30%. The business’s revenue was up .5% on a year-over-year basis. During the same period last year, the business earned $1.05 EPS. Equities analysts forecast that Hill-Rom Holdings, Inc. will post 5.05 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 21st will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date is Thursday, June 20th. Hill-Rom’s payout ratio is 17.68%.
WARNING: “Great West Life Assurance Co. Can Cuts Stake in Hill-Rom Holdings, Inc. (HRC)” was first posted by Stock Observer and is owned by of Stock Observer. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.thestockobserver.com/2019/05/25/great-west-life-assurance-co-can-cuts-stake-in-hill-rom-holdings-inc-hrc.html.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Recommended Story: Why is a lock-up period needed for an IPO?
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.